Family waits over a decade for compensation after toddler suffers paralysis post-vaccination

A U.S. family has received partial compensation more than a decade after their toddler was left severely paralyzed following routine childhood vaccinations, highlighting what critics describe as a slow and complex federal claims process.

In October 2013, 15-month-old Hayes Heller was administered several recommended vaccines, including those for influenza, pneumonia and diphtheria, tetanus and pertussis (DTaP). Within two weeks, the previously healthy child reportedly developed symptoms that rapidly progressed to paralysis.

Suspecting a vaccine-related injury, his parents filed a claim with the National Vaccine Injury Compensation Program (VICP), a federal scheme that compensates individuals found to have been injured by recommended vaccines.

According to medical records cited in a 2022 ruling by the United States Court of Federal Claims, Hayes had been meeting developmental milestones before the vaccinations.

Soon afterward, he became irritable, developed a fever and showed declining energy levels. Within weeks, his condition worsened dramatically.

His mother, Jenna Heller, recalled that he soon lost the ability to crawl, sit up or move his limbs.

“We woke up one day and he can’t sit up by himself … three days later, he can’t do anything but lay there,” she said, describing the onset of what doctors later termed extreme paralysis.

By December 2013, Hayes had been diagnosed with rapidly progressive neurological conditions, including dystonia and encephalopathy. Over time, he became quadriplegic and dependent on constant care.

Now 13 years old, Hayes remains unable to speak, uses a wheelchair and requires round-the-clock assistance, his family said.

Doctors initially explored alternative diagnoses, including Aicardi–Goutières syndrome, a rare inherited condition affecting the brain and immune system. Genetic testing, however, did not conclusively confirm the disorder.

Medical notes over the years reflected differing opinions. Some physicians suggested an autoimmune reaction possibly linked to vaccination, while others continued to describe the condition as a presumed genetic disorder.

The child also experienced seizures and underwent extensive treatments, including specialized therapies and procedures both within and outside the United States.

READ ALSO: New study reveals why COVID-19 vaccines caused rare blood clots

The Heller family began the VICP claims process in 2014 and formally filed in 2015, alleging that the vaccines had caused or significantly worsened their son’s condition.

It took nearly five years for the case to reach a hearing, during which it was reassigned to multiple special masters — judicial officers who oversee vaccine court proceedings.

At the January 2020 hearing, several medical experts testified for both sides. One neurologist who had previously dismissed the possibility of vaccine injury reportedly revised his opinion and supported the family’s claim.

Government experts disputed the allegation, citing the possible genetic disorder as an alternative explanation. However, one specialist acknowledged that Hayes did not meet all diagnostic criteria for that condition.

Despite this, the claim was initially denied in April 2022 after officials concluded the family had not met all required legal tests to establish causation.

The family sought review of the decision, arguing that their child’s injuries had been mischaracterised.

Later in 2022, a new special master found parts of the earlier ruling to be flawed and lacking a rational basis. In 2023, the VICP ultimately ruled in favour of the family, determining that the DTaP vaccine was the most likely cause based on available medical literature, although it could not conclusively identify a single vaccine.

Even after winning the case, the family said reimbursement proved limited. Officials required detailed receipts for expenses dating back to 2013, rejecting claims that lacked documentation or fell outside program guidelines.

Out-of-pocket costs included surgeries, specialist consultations, mobility equipment and full-time care over more than a decade. The family also reported losing income when the father’s business collapsed during the prolonged ordeal.

Ultimately, they received roughly 10 percent of their $3 million claim, according to Jenna Heller.

The program now provides funds through a trust to support Hayes’ ongoing medical and personal care needs, including nursing services, equipment and daily living supplies.

Observers say the case underscores longstanding concerns about the complexity and duration of the VICP process.

Wayne Rohde, a vaccine injury compensation expert, said cases involving new or unusual medical claims often require extensive expert testimony, which can significantly slow proceedings.

Families navigating the system are advised to maintain meticulous financial records and documentation, as reimbursement depends heavily on proof of expenses.

The case has renewed debate about how governments balance vaccine safety monitoring, compensation for rare adverse events and support for families facing lifelong medical challenges.